GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: A-16686A2 | MDL 62,198
Compound class:
Peptide
Comment: Ramoplanin is a glycolipodepsipeptide antibacterial with Gram-positive activity, originally isolated from the culture broth of Actinoplanes strain ATCC 33076 as a mixture of three components (ramoplanin A1, A2, and A3) [1,3].
We show the structure for ramoplanin A2 which is the major component. Note that the INN describes the mixture. As with other natural products, there is ambiguity in the precise stereochemisrty presented across web resources e.g., CHEMBL3989605 shows an alternate structure. |
|
|||||||||||||||||
| References |
|
1. Cavalleri B, Pagani H, Volpe G, Selva E, Parenti F. (1984)
A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics. J Antibiot (Tokyo), 37 (4): 309-17. [PMID:6547132] |
|
2. Fang X, Tiyanont K, Zhang Y, Wanner J, Boger D, Walker S. (2006)
The mechanism of action of ramoplanin and enduracidin. Mol Biosyst, 2 (1): 69-76. [PMID:16880924] |
|
3. Pallanza R, Berti M, Scotti R, Randisi E, Arioli V. (1984)
A-16686, a new antibiotic from Actinoplanes. II. Biological properties. J Antibiot (Tokyo), 37 (4): 318-24. [PMID:6547133] |
|
4. Wong MT, Kauffman CA, Standiford HC, Linden P, Fort G, Fuchs HJ, Porter SB, Wenzel RP, Ramoplanin VRE2 Clinival Stury Group. (2001)
Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis, 33 (9): 1476-82. [PMID:11588692] |
|
5. Zorzet A. (2014)
Overcoming scientific and structural bottlenecks in antibacterial discovery and development. Ups J Med Sci, 119 (2): 170-5. [PMID:24646118] |